AbstractBackgroundCystic fibrosis (CF) patients present a high incidence of glucose tolerance abnormalities. Altered insulin secretion combined with recommended high-fat intake could be associated with dysregulation of glucose and lipid metabolism. We examined postprandial glucose and lipid profiles during an oral glucose tolerance test (OGTT) and following a standardized high-fat test meal (TM).MethodsSixteen CF patients with normal glucose tolerance (NGT) or CF-related diabetes (CFRD) and 16 controls underwent a 4 h OGTT and a TM. We then measured plasma glucose, insulin, free fatty acid (FFA) and triglyceride (TG) concentrations.ResultsCF patients presented higher glucose excursion compared to controls after the OGTT and TM. However, in ...
Abnormal glucose metabolism states have increased in prevalence in cystic fibrosis (CF). Hypoglycaem...
AbstractBackgroundCystic fibrosis related diabetes (CFRD) with fasting hyperglycemia is found in 15%...
[eng] Objective: To evaluate insulin-secretion kinetics and insulin sensitivity in cystic fibrosis (...
AbstractBackgroundCystic fibrosis (CF) patients present a high incidence of glucose tolerance abnorm...
AbstractBackgroundAbnormal glucose tolerance is a frequent co-morbidity in cystic fibrosis patients ...
AbstractBackgroundPatients with cystic fibrosis and normoglycemia (CF-NGT) have higher but still “no...
AbstractBackgroundCystic fibrosis (CF) is characterized by chronic inflammation with increased oxida...
AbstractBackgroundRecent studies have identified hypertriglyceridemic cystic fibrosis patients (CF-T...
AbstractBackgroundA high fat calorie diet is advocated for patients with cystic fibrosis (CF) howeve...
Background: Consistently abnormal glucose levels on oral glucose tolerance test (OGTT) are the most ...
AbstractBackgroundIn non-cystic fibrosis (CF) subjects, the disposition index (DI) is a strong predi...
BackgroundHypoglycemia in cystic fibrosis (CF), in the absence of glucose-lowering therapies, has lo...
AbstractCystic fibrosis related diabetes (CFRD) is an important complication of CF that increases mo...
AbstractBackgroundThe recommended tests for evaluation of glucose tolerance in cystic fibrosis are t...
Cystic fibrosis (CF)-related diabetes is associated with increased mortality. We analysed the clinic...
Abnormal glucose metabolism states have increased in prevalence in cystic fibrosis (CF). Hypoglycaem...
AbstractBackgroundCystic fibrosis related diabetes (CFRD) with fasting hyperglycemia is found in 15%...
[eng] Objective: To evaluate insulin-secretion kinetics and insulin sensitivity in cystic fibrosis (...
AbstractBackgroundCystic fibrosis (CF) patients present a high incidence of glucose tolerance abnorm...
AbstractBackgroundAbnormal glucose tolerance is a frequent co-morbidity in cystic fibrosis patients ...
AbstractBackgroundPatients with cystic fibrosis and normoglycemia (CF-NGT) have higher but still “no...
AbstractBackgroundCystic fibrosis (CF) is characterized by chronic inflammation with increased oxida...
AbstractBackgroundRecent studies have identified hypertriglyceridemic cystic fibrosis patients (CF-T...
AbstractBackgroundA high fat calorie diet is advocated for patients with cystic fibrosis (CF) howeve...
Background: Consistently abnormal glucose levels on oral glucose tolerance test (OGTT) are the most ...
AbstractBackgroundIn non-cystic fibrosis (CF) subjects, the disposition index (DI) is a strong predi...
BackgroundHypoglycemia in cystic fibrosis (CF), in the absence of glucose-lowering therapies, has lo...
AbstractCystic fibrosis related diabetes (CFRD) is an important complication of CF that increases mo...
AbstractBackgroundThe recommended tests for evaluation of glucose tolerance in cystic fibrosis are t...
Cystic fibrosis (CF)-related diabetes is associated with increased mortality. We analysed the clinic...
Abnormal glucose metabolism states have increased in prevalence in cystic fibrosis (CF). Hypoglycaem...
AbstractBackgroundCystic fibrosis related diabetes (CFRD) with fasting hyperglycemia is found in 15%...
[eng] Objective: To evaluate insulin-secretion kinetics and insulin sensitivity in cystic fibrosis (...